MMWR Early Release - Vol. 71, January 7, 2022

["Morbidity and Mortality Weekly Report \(MMWR\) \(CDC\)" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

Reports on COVID-19 Associated with MIS-C and Diabetes  

January 7, 2022

EARLY RELEASE

Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021

Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 years — United States, March 1, 2020–June 28, 2021

PDF of these reports (link and link) 

MMWR Weekly COVID-19 Briefing Podcast: Week of December 27

 

The latest MMWR Weekly COVID-19 Briefing is live. This episode covers four reports, including reports highlighting an Omicron variant cluster among a single household in Nebraska, COVID-19 vaccine safety in children ages 5–11 years and more. Listen and subscribe on: Apple Podcasts, Stitcher, Spotify, and Google Play.